Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive vs Conventional Lipid-lowering in ARAS Stenting
NCT03521700Phase 3Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jun 2013
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin in atherosclerotic renal artery stenosis (ARAS), sponsored by Chinese Academy of Medical Sciences. Started Jun 2013; status: completed.
02
Drugs
rosuvastatin
03
Conditions
atherosclerotic renal artery stenosis (ARAS)
Beyond the preview
Go deeper on NCT03521700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03521700.